Preferred Medical continues to serve you by staying up to date on industry changes and drug updates that impact you.
Want to recieve drug news updates in your email inbox? Subscribe using the form below!
Drug News from Preferred Medical … Purdue Pharma, the company that manufactures OxyContin, is in the news. Again. On October 21, the Sackler family (company owners) agreed to pay $225 million to resolve their liability under the False Claims Act (FCA). On November 24, their company pled guilty to three felonies – two counts of …
Read More
Drug News from Preferred Medical … The New York Workers’ Compensation Board announced on November 18 it is “temporarily suspending the January 1, 2021, date for refill compliance, and a new date (likely spring, 2021), will be announced soon.” The original May 2019 regulations set the date for refill and renewal prescription compliance with the …
Read More
Drug News from Preferred Medical … In case you missed the notice on April 1, 2020, the FDA announced the following about Janssen Pharmaceuticals: “The Company made a business decision to permanently discontinue all Duragesic/fentanyl transdermal system. Product should be maintained on the formularies until the last batch produced expires (31 July 2021), in order …
Read More
Drug News from Preferred Medical … Naloxone medications (the generic naloxone or brand names Narcan and Evzio) are opioid antagonists that block the effects of an opioid in the brain, effectively reversing an overdose from a prescription or illegal opioid. First responders around the country use these drugs on a daily basis (130 people every …
Read More
Drug News from Preferred Medical … Since it appears that COVID-19 is going to impact our daily lives into the foreseeable future, continuing good hygiene basics makes sense. Practice social (more accurately, physical) distancing and wear a mask when that is not possible or is required by government, do not touch your face, cover coughs …
Read More
Drug News from Preferred Medical … On February 28, 2020 the FDA approved Advil® Dual Action that combines 250mg of acetaminophen and 125mg of ibuprofen into a single tablet. While over-the-counter (OTC) medications are not as prevalent at workers’ compensation PBMs as prescription medications (including the prescription versions of acetaminophen and ibuprofen), this new all-in-one …
Read More
Drug News from Preferred Medical … The FDA announced on April 1 it is “requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.” This includes the Zantac brand name variant, a popular drug used for stomach ulcers and conditions where the stomach produces excess acid. The FDA also recommends that …
Read More